In Innovation Leadership: Organizational Antibodies and Human Biology, Performance Coaching Innovation Practice Lead Melissa Quinn provides a look at what it takes to drive innovation in large organizations, overcoming both organizational and uniquely human barriers.
Innovation is the top priority in every global survey of CEOs - and yet few organizations are truly innovative. So, why is leading innovation so difficult?
First, human beings have survived as a species by avoiding uncertainty and today those predispositions are hard-wired into our biology. Second, organizations value predictability and compliance, and develop processes to drive out the anomalies that hamper efficiency and profitability.
As a result, leading innovation means fighting both biological and corporate antibodies – exploring uncertainty, taking calculated risks, and embracing ambiguity and failure. New tools are a part of the journey – but without investing in the personal transformation necessary to fight the biological drive to ‘safe ground’, leaders will never use the tools.
In this comprehensive article, Melissa Quinn outlines what the personal transformation entails and how to think about spurring this journey for yourself - and those around you.